Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

How Much Can Trump’s Childhood Cancer Funding Proposal Boost Drug Approvals?

Executive Summary

President Trump’s 2019 State of the Union Address broadly touched on the themes of funding childhood cancer research, drug pricing and eliminating HIV.

Advertisement

Related Content

US Initiative To End HIV Epidemic Will Boost PrEP Access
Sen. Grassley To Be "More Insistent" About Drug Firms' Testimony At Future Hearings
Democrats’ Drug Pricing Bills Echo Trump Ideas But Broad Republican Support Unlikely
US FDA’s Best Year Ever For New Drugs: CDER Novel Approvals Hit 59
Democrat-Controlled House Will Turn Up The Volume On Drug Pricing
Medicare's Foreign Price Bench-marking Will Only Hurt Bad Negotiators, HHS's Azar Argues
The Cost Of Drug Development: Can We All Just Agree It’s Expensive?
Keeping Track: US FDA Clears Three Novel Agents Over Three Days – Bavencio, Symproic And Xadago

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124703

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel